Evidence map›Paper›PMID 28686476›Full record

ArticleJournal of adolescent and young adult oncology2017

Oncology Physicians' Perspectives on Practices and Barriers to Fertility Preservation and the Feasibility of a Prospective Study of Pregnancy After Breast Cancer.

Shoshana M Rosenberg, Shari Gelber, Richard D Gelber, Ethan Krop, Larissa A Korde, Olivia Pagani, Ann H Partridge

Open access · greenAbstract read
In one paragraph

Article in Journal of adolescent and young adult oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. [Fertility preservation in breast cancer-A risk?]Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Infant feeding among women with a history of breast cancer.Journal of cancer survivorship : research and practice · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Shoshana M Rosenberg1 Dana-Farber Cancer Institute , Department of Medical Oncology, Boston, Massachusetts.
Shari Gelber2 Dana-Farber Cancer Institute , Department of Biostatistics and Computational Biology, Boston, Massachusetts.
Richard D Gelber2 Dana-Farber Cancer Institute , Department of Biostatistics and Computational Biology, Boston, Massachusetts.
Ethan Krop1 Dana-Farber Cancer Institute , Department of Medical Oncology, Boston, Massachusetts.
Larissa A Korde3 Division of Medical Oncology, University of Washington , Seattle, Washington.
Olivia Pagani4 Institute of Oncology and Breast Unit of Southern Switzerland , Bellinzona, Switzerland .
Ann H Partridge1 Dana-Farber Cancer Institute , Department of Medical Oncology, Boston, Massachusetts.
Dana-Farber Cancer Institute · USInstitute of Oncology Research · CHUniversity of Washington · US

Funding

Improving surgical decision-making in young women with breast cancerK01HS023680 · AHRQ · DANA-FARBER CANCER INST · PI ROSENBERG, SHOSHANA M · 2015 to 2019
$594k
AHRQ HHS K01 HS023680
6 · The paper itself

Abstract

purposePOSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer) is a prospective clinical trial assessing safety and pregnancy outcomes in premenopausal hormone receptor-positive breast cancer survivors (age ≤42) who interrupt endocrine therapy (ET) to attempt pregnancy. We sought to assess interest in this study and perspectives on fertility preservation (FP) among United States medical oncologists who had previously enrolled women at their institutions on select premenopausal endocrine studies.

methodsFrom August 2015 to December 2015, 301 investigators were invited to complete a web-based survey on behalf of their institution. We assessed FP practices and attitudes, barriers to discussing FP, and willingness to open/enroll women on POSITIVE.

resultsOf 93 respondents (31%), most were affiliated with an National Cancer Institute (NCI)-designated comprehensive cancer center (44%). Almost all said they usually or always discussed the issue of future fertility with patients (98%) and referred patients with fertility questions to specialists (97%). Over half of respondents cited discomfort with recommending women to stop ET, as well as perceived patient concern regarding ET interruption, as factors seen as influencing POSITIVE enrollment; however, 84% were willing to recommend trial participation for selected patients.

conclusionsMost providers reported discussing fertility with their young patients, indicating awareness of FP guidelines for cancer patients. While most oncologists said that they would be willing to recommend POSITIVE, many also expressed discomfort in endorsing women to stop ET temporarily, underscoring the need for prospective data regarding the safety of ET interruption. High willingness to recommend POSITIVE suggests the potential for successful accrual to this study, which addresses a critical issue for young breast cancer survivors.

Indexed as

Communication BarriersFertility PreservationHealth Knowledge, Attitudes, PracticeAdultBreast NeoplasmsFeasibility StudiesFemaleHumansMedical OncologyPractice Patterns, Physicians'PregnancyPregnancy OutcomeReferral and ConsultationSurvivorsWorkforceYoung Adultbreast cancerendocrine therapyfertilitypregnancy

Identifiers

PMID28686476
PMCPMC5649410
OpenAlexW2732520656

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.